Login

Switch On Your HIV Smarts.

Author Archives: Liz Highleyman

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

CROI 2015: Tenofovir Alafenamide and a New Maturation Inhibitor

, by Liz Highleyman

What’s new in the world of HIV drug development? CROI brought us updates on a potentially safer version of tenofovir and a new type of drug that just established proof-of-concept. Read More

PrEP Open House: What to Know if You’re Interested in PrEP

PrEP Open House: What to Know if You’re Interested in PrEP

, by Liz Highleyman

San Franciscans recently heard from people with experience taking PrEP and learned where to get access. Read More

HIV/Hepatitis Coinfection News from the Liver Meeting

HIV/Hepatitis Coinfection News from the Liver Meeting

, by Liz Highleyman

Get an update on how effective new interferon-free treatments are that treat hepatitis C for people with both HIV and HCV. Read More

Kaiser San Francisco: 500+ on PrEP, No New HIV Infections

Kaiser San Francisco: 500+ on PrEP, No New HIV Infections

, by Liz Highleyman

Kaiser Permanente's San Francisco Medical Center now has more than 500 members taking Truvada for PrEP -- and so far has seen no new HIV infections. Read more about what they've learned about their PrEP users. Read More

FDA Approves Harvoni for Hepatitis C

FDA Approves Harvoni for Hepatitis C

, by Liz Highleyman

A highly effective hepatitis C drug provides a cure for many patients, but is it too expensive? Read More